Inactive Instrument

Insiders ImmunoGen, Inc.

Equities

AbbVie CEO to Retire; COO Robert Michael Named Successor	21/02	MT
Immunogen, Inc. Announces Board Changes	12/02	CI
ImmunoGen Insider Sold Shares Worth $352,391, According to a Recent SEC Filing	07/02	MT
ImmunoGen Insider Sold Shares Worth $588,733, According to a Recent SEC Filing	07/02	MT
Immunogen Insider Sold Shares Worth $5,562,450, According to a Recent SEC Filing	19/01	MT
Immunogen Insider Sold Shares Worth $3,356,843, According to a Recent SEC Filing	09/11	MT
Immunogen Insider Sold Shares Worth $325,153, According to a Recent SEC Filing	09/11	MT
Immunogen Insider Sold Shares Worth $2,764,858, According to a Recent SEC Filing	19/23/19	MT
Immunogen Insider Sold Shares Worth $2,964,681, According to a Recent SEC Filing	20/23/20	MT
ImmunoGen Names Lauren White CFO	18/23/18	MT
Immunogen, Inc. Appoints Lauren White as Chief Financial Officer	18/23/18	CI
ImmunoGen, Inc. Announces Executive Changes	18/23/18	CI
Insider Sell: Immunogen	12/23/12	MT
Insider Sell: ImmunoGen	07/23/07	MT
Insider Sell: ImmunoGen	07/23/07	MT
Insider Sell: ImmunoGen	07/23/07	MT
ImmunoGen Chief Medical Officer Anna Berkenblit to Step Down, Successor Named	31/23/31	MT
ImmunoGen, Inc. Announces Executive Changes	31/23/31	CI
Cerevel Therapeutics Holdings Names Susan Altschuller CFO	10/23/10	MT
Immunogen, Inc. Appoints Isabel Kalofonos as Senior Vice President and Chief Commercial Officer	25/23/25	CI

No results for this search